| Released | Contributor | Author | Title | Pages | Price |
| 3-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 30-Nov-2009 | Reuters Investment Profile |
N/A
| Novadel Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for NVD | 13 |
$25 |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Novadel Pharma Inc. | 42 |
$65 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | NOVADEL PHARMA INC (NVD=US) 12-months forecast | 1 |
$15 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | NOVADEL PHARMA INC (NVD=US) 2-weeks forecast | 1 |
$10 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: NOVADEL PHARMA -- NVD | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: CADX , MNKD , MDVN , NVD -- DRUGS | 3 |
$4 |
| 27-Oct-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for NVD: the economy's impact on NVD's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
0.22% Nasdaq 
0.07 (31.82%) 
Research Reports
